NCT04629729 2026-03-19FT819 in Subjects With B-cell MalignanciesFate TherapeuticsPhase 1 Active not recruiting54 enrolled
NCT04155710 2025-12-24Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLLIovance Biotherapeutics, Inc.Phase 1 Completed7 enrolled
NCT04887259 2025-01-27Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AMLLava TherapeuticsPhase 1 Terminated16 enrolled